foxo4-dri senolytic peptide human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound Computational design of peptide targeting
Pay in 4 interest-free payments of $5.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10






























